1 Strachan, T. & Read, A. P. Human Molecular Genetics (Garland Science, 2011).

2 Veltman, J. A. & Brunner, H. G. De novo mutations in human genetic disease. Nature Rev. Genet. 13, 565–575 (2012).

3 Carlson, B. M. Human Embryology and Developmental Biology (Elsevier/Saunders, 2013).

4 Tjio, J. H. & Nichols, W. W. History and present status of human chromosome studies. In Vitro Cell Dev. Biol. 21, 305–313 (1985).

5 Antonarakis, S. E., Phillips, J. A. & Kazazian, H. H. Jr. Genetic diseases: diagnosis by restriction endonuclease analysis. J. Pediatr. 100, 845–856 (1982).

6 Boehm, J. S. & Hahn, W. C. Towards systematic functional characterization of cancer genomes. Nature Rev. Genet. 12, 487–498 (2011).

7 Gordon, D. J., Resio, B. & Pellman, D. Causes and consequences of aneuploidy in cancer. Nature Rev. Genet. 13, 189–203 (2012).

8 Crowe, F. W., Schull, W. J. & Neel, J. V. A Clinical, Pathological and Genetic Study of Multiple Neurofibromatosis (Charles C. Thomas, 1956).

9 Happle, R. Mosaicism in human skin. Understanding the patterns and mechanisms. Arch. Dermatol. 129, 1460–1470 (1993). This paper summarizes the data for a number of mosaic dermatological disorders and lays out the hypothesis for lethal genes manifesting as mosaic disorders.

10 Callum, P. et al. Gonosomal mosaicism for an NF1 deletion in a sperm donor: evidence of the need for coordinated, long-term communication of health information among relevant parties. Hum. Reprod. 27, 1223–1226 (2012).

11 Maertens, O. et al. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am. J. Hum. Genet. 81, 243–251 (2007).

12 Messiaen, L. et al. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum. Mutat. 32, 213–219 (2011).

13 Lee, N. P. et al. Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia. J. Med. Genet. 48, 353–357 (2011).

14 Best, D. H. et al. Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients. J. Med. Genet. 48, 358–360 (2011).

15 Harboe, T. L. et al. Mosaicism in segmental Darier disease: an in-depth molecular analysis quantifying proportions of mutated alleles in various tissues. Dermatology 222, 292–296 (2011).

16 Happle, R. Cutaneous manifestation of lethal genes. Hum. Genet. 72, 280 (1986).

17 Happle, R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J. Am. Acad. Dermatol. 16, 899–906 (1987).

18 McCune, D. & Bruch, H. Progress in pediatrics: osteodystrophia fibrosa. Am. J. Dis. Child 54, 806–848 (1937).

19 Albright, F., Butle, A. M., Hampton, A. O. & Smith, P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases. N. Engl. J. Med. 216, 727–746 (1937).

20 Happle, R. The McCune–Albright syndrome: a lethal gene surviving by mosaicism. Clin. Genet. 29, 321–324 (1986).

21 Weinstein, L. S. et al. Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N. Engl. J. Med. 325, 1688–1695 (1991). This is the landmark paper that describes the identification of mosaic mutations that cause the McCune–Albright syndrome.

22 Wiedemann, H. R. et al. The Proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. Eur. J. Pediatr. 140, 5–12 (1983).

23 Happle, R. How many epidermal nevus syndromes exist? A clinicogenetic classification. J. Am. Acad. Dermatol. 25, 550–556 (1991).

24 Wallis, G. A., Starman, B. J., Zinn, A. B. & Byers, P. H. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent. Am. J. Hum. Genet. 46, 1034–1040 (1990).

25 Williams, C. J. & Prockop, D. J. Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta. J. Biol. Chem. 258, 5915–5921 (1983).

26 Lamande, S. R., Dahl, H. H., Cole, W. G. & Bateman, J. F. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta. J. Biol. Chem. 264, 15809–15812 (1989).

27 Byers, P. H., Tsipouras, P., Bonadio, J. F., Starman, B. J. & Schwartz, R. C. Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen. Am. J. Hum. Genet. 42, 237–248 (1988).

28 Goriely, A. & Wilkie, A. O. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am. J. Hum. Genet. 90, 175–200 (2012). This review elegantly summarizes the disorders that manifest a paternal age effect and the biological basis of this phenomenon.

29 Conlin, L. K. et al. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum. Mol. Genet. 19, 1263–1275 (2010). This paper demonstrates the utility of the SNP array for detection of mosaicism and elucidation of the mechanisms by which the mosaicism arises.

30 Gottlieb, B., Beitel, L. K., Alvarado, C. & Trifiro, M. A. Selection and mutation in the “new” genetics: an emerging hypothesis. Hum. Genet. 127, 491–501 (2010).

31 Hirschhorn, K., Decker, W. H. & Cooper, H. L. Human intersex with chromosome mosaicism of type XY/XO. Report of a case. N. Engl. J. Med. 263, 1044–1048 (1960).

32 Erickson, R. P. Somatic gene mutation and human disease other than cancer: an update. Mutat. Res. 705, 96–106 (2010).

33 Hook, E. B. Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. Am. J. Hum. Genet. 29, 94–97 (1977).

34 Rodriguez-Santiago, B. et al. Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. Am. J. Hum. Genet. 87, 129–138 (2010).

35 Bras, J., Guerreiro, R. & Hardy, J. Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nature Rev. Neurosci. 13, 453–464 (2012).

36 Mardis, E. R. The impact of next-generation sequencing technology on genetics. Trends Genet. 24, 133–141 (2008). This is a thorough review of the basics of NGS technologies that underlie many of the recent discoveries of mosaic disorders.

37 Miller, J. F. et al. Fetal loss after implantation. A prospective study. Lancet 2, 554–556 (1980).

38 Hassold, T. et al. Human aneuploidy: incidence, origin, and etiology. Environ. Mol. Mutagen. 28, 167–175 (1996).

39 Vanneste, E. et al. Chromosome instability is common in human cleavage-stage embryos. Nature Med. 15, 577–583 (2009). This paper uses array CGH to reveal the surprisingly high frequency of chromosome abnormalities in the very early embryo.

40 Hassold, T. J. & Jacobs, P. A. Trisomy in man. Annu. Rev. Genet. 18, 69–97 (1984).

41 Daber, R. et al. Mosaic trisomy 17: variable clinical and cytogenetic presentation. Am. J. Med. Genet. A 155, 2489–2495 (2011).

42 Conlin, L. K. et al. Molecular analysis of ring chromosome 20 syndrome reveals two distinct groups of patients. J. Med. Genet. 48, 1–9 (2011).

43 Hsu, L. Y. et al. Incidence and significance of chromosome mosaicism involving an autosomal structural abnormality diagnosed prenatally through amniocentesis: a collaborative study. Prenat. Diagn. 16, 1–28 (1996).

44 Kelker, W. et al. Loss of 18q and homozygosity for the DCC locus: possible markers for clinically aggressive squamous cell carcinoma. Anticancer Res. 16, 2365–2372 (1996).

45 Gijsbers, A. C. et al. Three new cases with a mosaicism involving a normal cell line and a cryptic unbalanced autosomal reciprocal translocation. Eur. J. Med. Genet. 54, e409–e412 (2011).

46 Robberecht, C. et al. Meiotic errors followed by two parallel postzygotic trisomy rescue events are a frequent cause of constitutional segmental mosaicism. Mol. Cytogenet. 5, 19 (2012).

47 Hook, E. B. & Warburton, D. The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum. Genet. 64, 24–27 (1983).

48 Raffel, L. J., Mohandas, T. & Rimoin, D. L. Chromosomal mosaicism in the Killian/Teschler-Nicola syndrome. Am. J. Med. Genet. 24, 607–611 (1986).

49 Ballif, B. C. et al. Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am. J. Med. Genet. A 140, 2757–2767 (2006).

50 Cheung, S. W. et al. Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics. Am. J. Med. Genet. A 143, 1679–1686 (2007).

51 Laurie, C. C. et al. Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nature Genet. 44, 642–650 (2012).

52 Jacobs, K. B. et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nature Genet. 44, 651–658 (2012).

53 Abyzov, A. et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438–442 (2012).

54 Piotrowski, A. et al. Somatic mosaicism for copy number variation in differentiated human tissues. Hum. Mutat. 29, 1118–1124 (2008). This work investigates the frequency of copy number alterations in over 30 tissue samples from the same individual, revealing alterations that occur in only a single tissue in some cases, demonstrating the potential importance of tissue-specific mosaicism for human disease.

55 Bruder, C. E. et al. Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am. J. Hum. Genet. 82, 763–771 (2008).

56 Breckpot, J. et al. Differences in copy number variation between discordant monozygotic twins as a model for exploring chromosomal mosaicism in congenital heart defects. Mol. Syndromol. 2, 81–87 (2012).

57 Hafner, C. et al. Keratinocytic epidermal nevi are associated with mosaic RAS mutations. J. Med. Genet. 49, 249–253 (2012).

58 Hafner, C. et al. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc. Natl Acad. Sci. USA 104, 13450–13454 (2007). A candidate gene approach identifies PIK3CA as the cause of several mosaic dermatologic lesions. This is the first of a series of papers that demonstrates the importance of this pathway in mosaic dermatological disorders.

59 Hafner, C. et al. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J. Clin. Invest. 116, 2201–2207 (2006).

60 Lindhurst, M. J. et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. New Engl. J. Med. 365, 611–619 (2011). Here, the authors describe the first application of NGS to mosaic disorders in humans in a disorder that most famously afflicted Joseph Carey Merrick.

61 Lee, J. H. et al. De novo somatic mutations in components of the PI3K–AKT3–mTOR pathway cause hemimegalencephaly. Nature Genet. 44, 941–945 (2012).

62 Poduri, A. et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74, 41–48 (2012).

63 Riviere, J. B. et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nature Genet. 44, 934–940 (2012).

64 Lindhurst, M. J. et al. Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nature Genet. 44, 928–933 (2012).

65 Kurek, K. C. et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am. J. Hum. Genet. 90, 1108–1115 (2012).

66 Groesser, L. et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nature Genet. 44, 783–787 (2012).

67 Treon, S. P. et al. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N. Engl. J. Med. 367, 826–833 (2012).

68 Shiang, R. et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 335–342 (1994).

69 Rousseau, F. et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252–254 (1994).

70 Choate, K. A. et al. Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science 330, 94–97 (2010). This work documents the startling finding of the role of mitotic recombination in revertant mosaicism by demonstration of the correlation with normal patches of skin in a patient with icthyosis (and a documented mutation) with a normal genotype.

71 Jonkman, M. F. & Pasmooij, A. M. Realm of revertant mosaicism expanding. J. Invest. Dermatol. 132, 514–516 (2012).

72 Kearney, H. M., Kearney, J. B. & Conlin, L. K. Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations. Clin. Lab. Med. 31, 595–613 (2011).

73 Lindstrom, D. L., Leverich, C. K., Henderson, K. A. & Gottschling, D. E. Replicative age induces mitotic recombination in the ribosomal RNA gene cluster of Saccharomyces cerevisiae. PLoS Genet. 7, e1002015 (2011).

74 Romanelli, V. et al. Beckwith–Wiedemann syndrome and uniparental disomy 11p: fine mapping of the recombination breakpoints and evaluation of several techniques. Eur. J. Hum. Genet. 19, 416–421 (2011).

75 Cooper, W. N., Curley, R., Macdonald, F. & Maher, E. R. Mitotic recombination and uniparental disomy in Beckwith–Wiedemann syndrome. Genomics 89, 613–617 (2007).

76 Markert, C. L. & Petters, R. M. Manufactured hexaparental mice show that adults are derived from three embyronic cells. Science 202, 56–58 (1978).

77 Kalousek, D. K. & Vekemans, M. Confined placental mosaicism and genomic imprinting. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 14, 723–730 (2000).

78 Hoornaert, K. P. et al. The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene. J. Med. Genet. 43, 406–413 (2006).

79 Kingsbury, M. A., Yung, Y. C., Peterson, S. E., Westra, J. W. & Chun, J. Aneuploidy in the normal and diseased brain. Cell. Mol. Life Sci. 63, 2626–2641 (2006).

80 Yurov, Y. B. et al. Unexplained autism is frequently associated with low-level mosaic aneuploidy. J. Med. Genet. 44, 521–525 (2007).

81 Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445–449 (2007).

82 Marshall, C. R. et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477–488 (2008).

83 Gollob, M. H. et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N. Engl. J. Med. 354, 2677–2688 (2006).

84 Malan, V., Vekemans, M. & Turleau, C. Chimera and other fertilization errors. Clin. Genet. 70, 363–373 (2006).

85 Winberg, J. et al. Chimerism resulting from parthenogenetic activation and dispermic fertilization. Am. J. Med. Genet. A 152, 2277–2286 (2010).

86 Yamazawa, K. et al. Parthenogenetic chimaerism/mosaicism with a Silver–Russell syndrome-like phenotype. J. Med. Genet. 47, 782–785 (2010).

87 Shin, S. Y., Yoo, H. W., Lee, B. H., Kim, K. S. & Seo, E. J. Identification of the mechanism underlying a human chimera by SNP array analysis. Am. J. Med. Genet. A 158, 2119–2123 (2012).

88 Wilson, M. et al. The clinical phenotype of mosaicism for genome-wide paternal uniparental disomy: two new reports. Am. J. Med. Genet. A 146, 137–148 (2008).

89 Romanelli, V. et al. Constitutional mosaic genome-wide uniparental disomy due to diploidisation: an unusual cancer-predisposing mechanism. J. Med. Genet. 48, 212–216 (2011).

90 Yu, N. et al. Disputed maternity leading to identification of tetragametic chimerism. N. Engl. J. Med. 346, 1545–1552 (2002).

91 Vogt, J. et al. Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation. Hum. Mutat. 32, E2134–E2147 (2011).

92 Kaplan, L. et al. Monozygotic twins discordant for neurofibromatosis 1. Am. J. Med. Genet. A 152, 601–606 (2010).

93 Fraga, M. F. et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA 102, 10604–10609 (2005).

94 Harder, A. et al. Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5′ untranslated region, exon and intron 1. Twin Res. Hum. Genet. 13, 582–594 (2010).